Recently, the crucial role of Peli1 in regulating phosphatidylinositol-3-kinase (PI3K)-AKT signaling, the major effector pathway that reprograms cellular metabolism in cancer, has been revealed [185,199]. This evidence concerns the gene AKT1 and cancer.